| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $12,514,864 ) (Continued on the next page) |
| | 2026 | 2026 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HG013710 | Advancing Perinatal Genomic Discoveries through Patient Engagement and Data Sharing | 000 | 2 | NIH | 7/24/2026 | $716,697 |
| | 2026 | 2026 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01MH137191 | 7/7-PsycheMERGE: Advancing Precision Psychiatry | 000 | 3 | NIH | 6/9/2026 | $784,128 |
| | 2026 | 2026 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01HG013796 | Making Genomic Medicine Routine in a Rural Healthcare System | 002 | 3 | NIH | 8/18/2026 | $478,240 |
| | 2026 | 2026 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01HG013796 | Making Genomic Medicine Routine in a Rural Healthcare System | 002 | 3 | NIH | 8/18/2026 | $182,638 |
| | 2026 | 2026 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | T2554942 | Addiction Medicine Fellowship | 01 | 2 | HRSA | 8/5/2026 | $0 |
| | 2026 | 2026 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | T2554942 | Addiction Medicine Fellowship | 00 | 2 | HRSA | 5/21/2026 | $594,802 |
| | 2026 | 2026 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R4354926 | Autism Secondary Data Analysis Program | 00 | 2 | HRSA | 6/2/2026 | $60,000 |
| | 2026 | 2026 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | NU58DP007587 | The Innovative Cardiovascular Health Program | 00 | 4 | CDC | 8/20/2026 | $715,000 |
| | 2026 | 2026 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | H79TI084778 | Free2BMom | 002 | 5 | SAMHSA | 7/22/2026 | $524,730 |
| | 2026 | 2026 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HD104938 | Characterizing the spectrum of genomic and phenotypic variation in cerebral palsy | 000 | 5 | NIH | 7/31/2026 | $672,991 |
| | 2026 | 2026 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HL159182 | Improving Risk Stratification in Familial Hypercholesterolemia (RISK-FH) | 000 | 5 | NIH | 8/24/2026 | $722,234 |
| | 2026 | 2026 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | H7646012 | Ryan White Part C Outpatient EIS Program | 01 | 5 | HRSA | 5/7/2026 | $291,601 |
| | 2026 | 2026 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | H7646012 | Ryan White Part C Outpatient EIS Program | 00 | 5 | HRSA | 4/1/2026 | $58,318 |
| | 2026 | 2026 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01DK122503 | Integrative Approaches to Identifying Function and Clinical Significance of Adiposity Susceptibility Genes | 001 | 6 | NIH | 8/28/2026 | $857,714 |
| | 2026 | 2026 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U18DP006917 | Comprehensive Analysis, Surveillance, and Statistics Initiative for Diabetes in the Young (CASSIDY) | 00 | 2 | CDC | 8/15/2026 | $499,996 |
| | 2026 | 2026 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U18DP006917 | Comprehensive Analysis, Surveillance, and Statistics Initiative for Diabetes in the Young (CASSIDY) | 00 | 2 | CDC | 8/15/2026 | $199,038 |
| | 2026 | 2026 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01MH074090 | Gene Dosage Imbalance in Neurodevelopmental Disorders | 000 | 20 | NIH | 5/25/2026 | $775,096 |
| | 2026 | 2026 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R33HL161775 | Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH | 000 | 5 | NIH | 2/17/2026 | $726,344 |
| | 2026 | 2026 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HL172022 | Blood Trauma, Vascular Remodeling, and Vasoregulation with Total Body Continuous Versus Pulsatile Artificial Circulation | 000 | 3 | NIH | 5/20/2026 | $629,086 |
| | 2026 | 2026 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | T6249313 | Integrated Substance Use Disorder (SUD) Training Program | 00 | 4 | HRSA | 5/22/2026 | $513,893 |
| | 2026 | 2026 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HL179171 | Improving the Detection and Understanding of Aortic Aneurysms through Large-Scale Radiologic and Genetic Risk Assessments | 000 | 1 | NIH | 7/8/2026 | $727,665 |
| | 2026 | 2026 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HL183397 | Titin, Genome-First: Disease Spectrum and Modifiers of Heritable Cardiomyopathy | 000 | 1 | NIH | 8/19/2026 | $823,655 |
| | 2026 | 2026 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HL179687 | Assessing the relationship between extreme heat and cardiovascular and pulmonary outcomes to identify strategies for health system intervention | 002 | 2 | NIH | 8/6/2026 | $660,360 |
| | 2026 | 2026 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R33DA059880 | Evaluation of a peer recovery support program adapted to target retention in clinic-based medication for opioid use disorder treatment | 001 | 3 | NIH | 7/22/2026 | $668,508 |
| | 2026 | 2025 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HL179687 | Assessing the relationship between extreme heat and cardiovascular and pulmonary outcomes to identify strategies for health system intervention | 001 | 1 | NIH | 3/5/2026 | $0 |
| | 2026 | 2025 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HL179687 | Assessing the relationship between extreme heat and cardiovascular and pulmonary outcomes to identify strategies for health system intervention | 001 | 1 | NIH | 3/5/2026 | $0 |
| | 2026 | 2025 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HL179687 | Assessing the relationship between extreme heat and cardiovascular and pulmonary outcomes to identify strategies for health system intervention | 000 | 1 | NIH | 1/30/2026 | $0 |
| | 2026 | 2025 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HL179687 | Assessing the relationship between extreme heat and cardiovascular and pulmonary outcomes to identify strategies for health system intervention | 000 | 1 | NIH | 1/30/2026 | $0 |
| | 2026 | 2025 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01HG013796 | Making Genomic Medicine Routine in a Rural Healthcare System | 001 | 2 | NIH | 3/19/2026 | $0 |
| | 2026 | 2025 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01HG013796 | Making Genomic Medicine Routine in a Rural Healthcare System | 001 | 2 | NIH | 3/19/2026 | $0 |
| | 2026 | 2025 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01HG013796 | Making Genomic Medicine Routine in a Rural Healthcare System | 000 | 2 | NIH | 2/20/2026 | $0 |
| | 2026 | 2025 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01HG013796 | Making Genomic Medicine Routine in a Rural Healthcare System | 000 | 2 | NIH | 2/20/2026 | $0 |
| | 2026 | 2025 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | T2554942 | Addiction Medicine Fellowship | 01 | 1 | HRSA | 3/5/2026 | $0 |
| | 2026 | 2025 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | NU58DP007587 | The Innovative Cardiovascular Health Program | 01 | 3 | CDC | 12/9/2025 | $0 |
| | 2026 | 2025 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | NU58DP007587 | The Innovative Cardiovascular Health Program | 00 | 4 | CDC | 8/20/2026 | $0 |
| | 2026 | 2025 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | H79TI084778 | Free2BMom | 001 | 4 | SAMHSA | 1/15/2026 | $0 |
| | 2026 | 2025 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | H79TI084778 | Free2BMom | 000 | 4 | SAMHSA | 1/13/2026 | $0 |
| | 2026 | 2025 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | H7646012 | Ryan White Part C Outpatient EIS Program | 06 | 4 | HRSA | 3/9/2026 | $0 |
| | 2026 | 2025 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | H7646012 | Ryan White Part C Outpatient EIS Program | 05 | 4 | HRSA | 1/7/2026 | $0 |
| | 2026 | 2025 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | H7646012 | Ryan White Part C Outpatient EIS Program | 04 | 4 | HRSA | 12/29/2025 | $0 |
| | 2026 | 2025 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | H7646012 | Ryan White Part C Outpatient EIS Program | 03 | 4 | HRSA | 12/1/2025 | $0 |
| | 2026 | 2025 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HG011799 | Real-time genetic diagnosis at the point of care | 000 | 5 | NIH | 3/31/2026 | $0 |
| | 2026 | 2025 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U18DP006917 | Comprehensive Analysis, Surveillance, and Statistics Initiative for Diabetes in the Young (CASSIDY) | 00 | 2 | CDC | 8/15/2026 | $0 |
| | 2026 | 2025 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | T6249313 | Integrated Substance Use Disorder (SUD) Training Program | 02 | 3 | HRSA | 2/19/2026 | $0 |
| | 2026 | 2025 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | T6249313 | Integrated Substance Use Disorder (SUD) Training Program | 01 | 3 | HRSA | 11/25/2025 | $0 |
| | 2026 | 2025 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R33DA059880 | Evaluation of a peer recovery support program adapted to target retention in clinic-based medication for opioid use disorder treatment | 000 | 2 | NIH | 12/2/2025 | $0 |
| | 2026 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | D5837570 | Residency Training in Primary Care | 02 | 5 | HRSA | 8/11/2026 | -$367,870 |
| | 2026 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | NU58DP007587 | The Innovative Cardiovascular Health Program | 01 | 3 | CDC | 12/9/2025 | $0 |
| | 2026 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | NU58DP007587 | The Innovative Cardiovascular Health Program | 00 | 4 | CDC | 8/20/2026 | $0 |
|
